Citation:Carrington C, Stone L, Koczwara B, Searle C, Siderov J, Stevenson B, et al 2010

From Cancer Guidelines Wiki

Citation

Carrington C, Stone L, Koczwara B, Searle C, Siderov J, Stevenson B, et al. The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy. Asia Pac J Clin Oncol 2010 Sep;6(3):220-37 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/20887505.



Critical appraisals

Critical appraisal link Clinical questionAssigned toStatus
Cancer chemotherapy medication safety guidelinesChristine Carringtoncompleted

Compare quality appraisals for each clinical question

Cited by

  1. COSA:Cancer chemotherapy medication safety guidelines/Guideline development process
  2. How can risk assessment and quality assurance activities minimise errors in cancer therapy?
  3. How should chemotherapy be safely administered via different routes?
  4. How should information be presented in the medication order to minimise errors?
  5. How should information be presented on a medication label for cancer therapy to minimise errors?
  6. What actions should be performed post-administration of cancer therapy to maximise safety?
  7. What additional safety practices should be followed when providing oral cancer therapy?
  8. What are the documentation requirements to support the safe provision of cancer therapy?
  9. What are the responsibilities of the Nurse when administering cancer therapy?
  10. What are the responsibilities of the Pharmacist when dispensing and supplying cancer therapy?
  11. What are the responsibilities of the Prescriber when prescribing cancer therapy and associated medications?
  12. What are the special safety considerations when providing intrathecal cancer therapy?
  13. What competencies and skills are required when administering cancer therapy?
  14. What competencies and skills are required when dispensing and supplying cancer therapy?
  15. What factors should be taken into account when using electronic systems to support the delivery of cancer therapy?
  16. What information and assessments are required prior to administering cancer therapy?
  17. What information should be included in a treatment protocol for cancer therapy?
  18. What information should be provided to patients and carers about the cancer therapy?
  19. What is best practice when dispensing and supplying intrathecal therapy?
  20. What is best practice when dispensing oral cancer treatment (chemotherapy and targeted therapy)?
  21. What is best practice when prescribing intrathecal therapy?
  22. What is best practice when prescribing oral cancer treatment (chemotherapy and targeted therapy)?
  23. What is the procedure for the Nurse when verifying cancer therapy and related medication prior to administration?
  24. What is the procedure for the Pharmacist when clinically verifying cancer prescriptions?
  25. What resources are required for the safe provision of cancer therapy?
  26. What safety processes should be followed for preparation and delivery of cancer therapy?
  27. What special considerations are required to minimise risk when providing cancer therapy to older adults?